Discontinued — last reported Q2 '25
International Flavors & Fragrances Pharma Solutions — Selling and administrative expenses decreased by 68.8% to $10.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 61.5%, from $26.00M to $10.00M. Over 2 years (FY 2022 to FY 2024), Pharma Solutions — Selling and administrative expenses shows an upward trend with a 19.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising ratio of these expenses to revenue may indicate operational inefficiency, while a declining ratio suggests improved scalability and cost control.
Encompasses the overhead costs associated with managing the Pharma Solutions segment, including sales force compensation...
Comparable to SG&A expenses reported by peers in the specialty ingredients and life sciences sectors.
iff_segment_pharma_solutions_selling_and_administrative_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.25M | $20.25M | $20.25M | $20.25M | $24.75M | $24.75M | $24.75M | $24.75M | $28.00M | $26.00M | $30.00M | $31.00M | $32.00M | $10.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +22.2% | +0.0% | +0.0% | +0.0% | +13.1% | -7.1% | +15.4% | +3.3% | +3.2% | -68.8% |
| YoY Change | — | — | — | — | +22.2% | +22.2% | +22.2% | +22.2% | +13.1% | +5.1% | +21.2% | +25.3% | +14.3% | -61.5% |